Quantcast

Latest Biomarker Stories

2014-05-29 16:26:10

VANCOUVER, May 29, 2014 /PRNewswire/ - Augurex Life Sciences Corp. announces a ground-breaking body of new data that will publish during the European League Against Rheumatism (EULAR) Annual Congress of Rheumatology taking place June 11-14 in Paris. Investigators will present the studies listed in the schedule below, which to date along with other publications, represent over 2000 patients evaluated with the 14-3-3 eta blood test. This follows the very recent publication of a study...

2014-05-28 12:30:34

Strand celebrates the largest commercial adoption of genomics in cancer care to date ROCKVILLE, Md., May 28, 2014 /PRNewswire/ -- Strand Genomics Inc. (Strand), a global leader in clinical genomics, has announced a major initiative with Health Care Global Enterprises, Ltd (HCG) to provide personalized genomics services for oncology. Strand's clinical genomics solutions for oncology offered by the Strand-Triesta Center for Cancer Genomics (Strand-Triesta) include both cancer risk...

2014-05-27 23:07:20

The emerging markets, including China and India, have become a business hub for companies engaged in the development and marketing of diagnostic imaging systems. http://www.marketsandmarkets.com/Market-Reports/diagnostic-imaging-market-411.html (PRWEB) May 27, 2014 The report “Diagnostic Imaging Market by X-ray Systems (Digital, Analog, Portable), Computed Tomography, Ultrasound Imaging Systems (2D, 3D, 4D, Doppler), MRI Machines (Closed & Open), and Nuclear Imaging Systems (SPECT,...

2014-05-27 23:05:12

Emerging biotech firm appoints prominent scientist/inventor as well as distinguished scientists/entrepreneurs to enhance scientific and business capabilities. Fayetteville, Ark., and Seattle, Wash. (PRWEB) May 27, 2014 Dr. Patricia Beckmann, a prominent scientist and inventor has been appointed to the combined roles of chief scientific officer (CSO) and chief business officer (CBO) at Ascendant Dx. In addition, Dr. Mark Boguski and Dr. Isaac Kohane have joined the Scientific Advisory...

2014-05-27 08:28:53

WALTHAM, Mass., May 27, 2014 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., today announced that clinical trial data on entinostat will be presented in two posters during the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) being held May 30 - June 3, 2014, in Chicago. The first poster, titled "Phase 2 study investigating the safety, efficacy, and surrogate biomarkers of response to 5-azacitidine (5-AZA) and entinostat in advanced breast cancer," is being...

2014-05-23 20:21:52

GERMANTOWN, Maryland and HILDEN, Germany, May 23, 2014 /PRNewswire/ -- - Clinically proven companion diagnostic gains U.S. approval to guide use of Amgen's Vectibix(R) (panitumumab) in treatment of metastatic colorectal cancer - FDA approval (PMA) of therascreen KRAS RGQ PCR Kit for Vectibix expands QIAGEN's leadership in molecular companion diagnostics for personalized healthcare - QIAGEN driving the adoption of molecular tests...

2014-05-23 08:23:59

SHANGHAI, May 23, 2014 /PRNewswire/ -- Targos GmbH, a leader in clinical biomarker services, and WuXi PharmaTech (NYSE:WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today announced a strategic biomarker collaboration. Through this collaboration, Targos will provide know-how, services, and the quality standards to support WuXi's bioanalytical work for pharmaceutical customers. The...

2014-05-21 16:27:24

CASTLE ROCK, Colo., May 21, 2014 /PRNewswire/ -- Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its CE Marked APPY1(TM) Test, a rapid, multiple biomarker-based assay for identifying patients that are at low risk for appendicitis, today announced it will participate in the 11(th) Annual Craig-Hallum Institutional Investor Conference, to be held May 28, 2014, at the Minneapolis Marriott City Center. Steve Lundy,...

2014-05-21 08:29:37

MOUNTAIN VIEW, Calif., May 21, 2014 /PRNewswire-USNewswire/ -- The Open Medicine Institute (OMI), an organization with a mission to improve health care by applying a multi-disciplinary, "big data" approach, today announced that it will begin development of a biomarker for Chronic Fatigue Syndrome (CFS) and other prevalent, chronic but difficult-to-diagnose diseases. Plans are in place for development of two key tests - a detection biomarker based on RNA expression data from patients...

2014-05-20 23:07:09

A funding round of $2 million will help biotech firm carry out clinical trials and commercialization of early breast cancer detection test. Fayetteville, Arkansas and Vancouver, Washington (PRWEB) May 20, 2014 The average non-high risk American woman will undergo at least one, if not more, biopsies to evaluate a suspicious mass within her lifetime. Women within the high-risk population will undergo multiple biopsies as well as endure more frequent follow up breast imaging tests. The costs...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related